VAERS reports by lot

Novartis Vaccines Meningococcal lot ABX795AA: VAERS reports

27 VAERS reports list lot ABX795AA as a Novartis Vaccines Meningococcal vaccine, received between 2019-07-02 and 2020-07-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
11%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal2619%
General / Systemic (non-local)2619%
Neurological2216%
Injection-site / Local reaction2115%
Gastrointestinal1914%
Cardiac / Cardiovascular1410%
Dermatological (non-injection-site)43%
Thrombotic / Hematological32%
Allergic / Anaphylactic32%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 9).

Florida9
New York5
Massachusetts4
Michigan2
Pennsylvania2
North Carolina1
South Carolina1
Alabama1
Louisiana1

Reports by month received

2019-0714
2019-088
2019-091
2019-101
2019-112
2020-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.